<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: BioVeris Corporation (Web)</title><link>http://www.zibb.com/healthcare/theme/cq/BioVeris+Corporation</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/healthcare/theme/cq/BioVeris+Corporation" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Tue, 24 Nov 2009 01:34:04 GMT</pubDate><lastBuildDate>Tue, 24 Nov 2009 01:34:04 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: BioVeris Corporation (Web)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/healthcare/theme/cq/BioVeris+Corporation</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Roche - Media News - Roche completes acquisition of Igen</title><link>http://www.roche.com/med-cor-2004-02-16</link><description>The acquisition of Igen ends a long standing patent dispute and gives Roche broad access to the human in-vitro diagnostics (IVD) immunochemistry sector. Valued at 7.5 billion Swiss francs, immunochemistry is the biggest segment of the in-vitro diagnostics market.</description><guid>http://www.roche.com/med-cor-2004-02-16</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.roche.com" /></item><item><title>Immunoassay Systems - Used Surplus Equipment</title><link>http://www.labx.com/v2/newad.cfm?catID=416</link><description>Receive Email Notifications via LabX Alerts! Enter your favorite search terms, favorite LabX category, or favorite LabX seller and be notified daily, weekly, or monthly by email when ads are entered which match your criteria.</description><guid>http://www.labx.com/v2/newad.cfm?catID=416</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.labx.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Roche Completes Acquisiti...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=61865</link><description>2007 JUL 13 - (NewsRx.com) -- Roche Diagnostics today announces that it has completed its acquisition of BioVeris. Roche signed the merger agreement with BioVeris for approximately $600 million on April 4, 2007.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=61865</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Licensing Agreements - BioVeris completes additional vaccine lice...
      </title><link>http://www.newsrx.com/newsletters/Vaccine-Weekly/2007-02-28/420228200710VW.html</link><description>',250)" onMouseout="hideddrivetip()"&gt;Haemophilus influenzae type b (Hib) components in new vaccine A substance or group of substances meant to cause the immune system to respond to a tumor or to microorganisms, such as bacteria or viruses.</description><guid>http://www.newsrx.com/newsletters/Vaccine-Weekly/2007-02-28/420228200710VW.html</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.newsrx.com" /></item><item><title>Industry News Feeds : Press Room : Micromedex</title><link>http://www.micromedex.com/pressroom/news_feeds/?story_ID=97713&amp;category=16</link><description>Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.</description><guid>http://www.micromedex.com/pressroom/news_feeds/?story_ID=97713&amp;category=16</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.micromedex.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Roche to acquire BioVeris...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=55026</link><description>2007 APR 27 - (NewsRx.com) -- Roche and BioVeris Corporation announced today that they have signed a definitive merger agreement under which Roche will acquire 100% ownership in BioVeris for 21.5 US dollars per share in cash or a total of approximately 600 million US dollars.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=55026</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Roche Sends Preliminary 2...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=45568</link><description>payment does not represent full satisfaction of Roche's obligations for 2004 out-of-field sales and BioVeris expressly reserves all rights to seek additional payments. Additionally, BioVeris does not believe that this payment is indicative of amounts that will be owed for years after 2004.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=45568</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - BioVeris Licenses Vaccine...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=10795</link><description>, it completed a Technology License Agreement with Baxter Healthcare Corporation for exclusive patent rights to a broad portfolio of vaccine candidates.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=10795</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Tandem Labs to offer BioV...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=34464</link><description>Tandem acquired the BioVeris M-SERIES analyzer, reagents and bioverification training to expand their offering of premiere assay technologies for biotechnology and pharmaceutical customers.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=34464</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - BioVeris Launches New Pro...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=48916</link><description>/PRNewswire-FirstCall/ -- BioVeris Corporation (Nasdaq: BIOV) announced today that it has introduced for sale eight new products for use in life science research.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=48916</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Biotech News: Morning Ale...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=53862</link><description>BioVeris Corporation engages in the development, manufacture, and marketing of diagnostic products for the detection and measurement of biological and chemical substances.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=53862</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - BioVeris Completes New Li...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=17870</link><description>Under the agreement with UMA, the Company has licensed exclusive rights to commercialize products for possible use in the prevention, diagnosis and treatment of all chlamydial infections, including the disease, Chlamydia, caused by the bacterium, Chlamydia trachomatis.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=17870</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Afternoon Movers: Roche t...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=53727</link><description>Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Today's activity on the markets has brought these companies to the attention of our research team.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=53727</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Microplate Readers - Used Surplus Equipment</title><link>http://www.labx.com/v2/newad.cfm?CatID=44&amp;Page=2</link><description>Make: Molecular Devices LJL Model: Acquest Price $10,000.00 Here is a nice LJL Acquest capable of reading 96, 384 and 1536 well plates, acquired from a down sized HTS project. Appears to have had very little use with plate counter reading less than 2000 plates and continous lamp reading 100 hours.</description><guid>http://www.labx.com/v2/newad.cfm?CatID=44&amp;Page=2</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.labx.com" /></item><item><title>Promotional Offer from BioVeris Corporation! Announcement</title><link>http://www.labx.com/v2/adsearch/detail3.cfm?adnumb=309455</link><description>Now through March 31, 2007, BioVeris Corporation is offering you the M-SERIES Promotional Package. You will receive an M-SERIES M1M or M1MR for only $39,000 when you purchase $18,875 worth of any combination of the BioVeris reagents listed below:</description><guid>http://www.labx.com/v2/adsearch/detail3.cfm?adnumb=309455</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.labx.com" /></item><item><title>Immunoassay Systems Company Links</title><link>http://www.labx.com/v2/lablinks/linkscategory.cfm?catID=416</link><description>BioVeris provides instruments, reagents, labels, beads, and kits that utilize electrochemiluminescent (ECL) technology to measure almost any bimolecular interaction, including: immunoassays for pathogen, cytokine, and small molecule detection.</description><guid>http://www.labx.com/v2/lablinks/linkscategory.cfm?catID=416</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.labx.com" /></item><item><title>Announcement - Used Surplus Equipment</title><link>http://www.labx.com/v2/newad.cfm?CatID=51&amp;AdtypeID=8,22&amp;Page=7</link><description>Make: Mindray Model: DC-6 Category: Ultrasound Mindray DC-6 Ultrasound Systems Now Available in US from Physician's Resource Network DC-6 Harmonic color Doppler full body imaging system - Special Price $39,990 including 2 probes, DICAOM, USB storage and 18 month soup to nuts warranty.</description><guid>http://www.labx.com/v2/newad.cfm?CatID=51&amp;AdtypeID=8,22&amp;Page=7</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.labx.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Tandem Labs to Offer BioV...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=31673</link><description>Tandem acquired the BioVeris M-SERIES(R) Analyzer, reagents and BioVerification training to expand their offering of premiere assay technologies for biotechnology and pharmaceutical customers.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=31673</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Roche to Acquire BioVeris...
      </title><link>http://www.pharmacychoice.com/News/article.cfm?Article_ID=53728</link><description>This acquisition will allow Roche Diagnostics to expand its immunochemistry business from the human diagnostics field into new market segments such as life science research, life science development, patient self testing, veterinary testing, drug discovery, drug development and clinical trials.</description><guid>http://www.pharmacychoice.com/News/article.cfm?Article_ID=53728</guid><category domain="http://www.zibb.com">BioVeris Corporation</category><pubDate /><source url="http://www.pharmacychoice.com" /></item></channel></rss>